Does Kosmico claim every specialist feature is stronger?
No. The claim being tested is workflow integration. Specialist tools may remain preferable for particular capabilities or established institutional processes.
Workflow comparison
A conventional research stack can be powerful because each specialist tool is mature. Its cost is the manual work required to move sources, context, decisions, files, and citations between them.
Kosmico's design bet is that research improves when specialist surfaces share one project state and the agent can act across them with explicit permissions.
Zotero, Overleaf, notebooks, academic databases, and team chat each solve important problems. A team may prefer them for established workflows, institutional integrations, or a specific specialist capability.
Manual actions, application switches, duplicated context, stale copies, recovery after interruption, and artifact completeness are benchmark outcomes, not cosmetic details. The controlled benchmark holds the model and corpus constant to measure that workflow layer.
| Criterion | Kosmico | Conventional stack |
|---|---|---|
| Context | One project context selected for the task | Context copied or reconnected across applications |
| Artifacts | Literature, notes, code, references, and manuscript in one project | Artifacts remain in their specialist tools |
| Automation | Agent actions across supported project surfaces and permissions | Integrations, exports, scripts, and manual handoffs |
| Control | One workspace policy and project permissions | Independent permissions, storage, and policies per service |
Official live source
The live product profile is temporarily unavailable. This page is withholding changeable product facts until the official source responds.
No. The claim being tested is workflow integration. Specialist tools may remain preferable for particular capabilities or established institutional processes.
The benchmark measures completion, wall and human time, manual actions, application switches, artifact completeness, recovery, evidence quality, and cost across both real-world and controlled conditions.